Wordt geladen...

The molecular basis for RET tyrosine-kinase inhibitors in thyroid cancer

RET receptor tyrosine kinase (RTK) acts as an ontogenetic driver in several human malignancies, including papillary and medullary thyroid carcinoma, lung adenocarcinoma, colorectal carcinoma, Spitzoid neoplasms, salivary gland carcinoma and chronic myeloproliferative disorders, secondary to as diver...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Best Pract Res Clin Endocrinol Metab
Hoofdauteurs: De Falco, Valentina, Carlomagno, Francesca, Li, Hong-yu, Santoro, Massimo
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: 2017
Onderwerpen:
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5624797/
https://ncbi.nlm.nih.gov/pubmed/28911727
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.beem.2017.04.013
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!